关于实施阿尔法-1抗素的自我管理的建议
María Torres-Durán1, José Luis López-Campos2,3, Myriam Calle Rubio4
1Pneumology Department, Hospital Álvaro Cunqueiro, NeumoVigo I+i Research Group, IIS Galicia Sur, Vigo, Spain.
International journal of chronic obstructive pulmonary disease
|August 10, 2023
概括
自治α-1抗素 (AAT) 治疗可以改善患者的独立性. 本研究为实施AAT自我管理计划提供专家建议,重点关注患者选择,医疗保健专业人员角色,培训和支持.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 患者护理 患者护理
背景情况:
- 阿尔法-1抗素 (AAT) 缺乏症需要通过静脉注射进行外源性AAT治疗.
- 目前的AAT输液计划可能会对患者的生活质量和独立性产生负面影响.
- 自治AAT提供了一个潜在的解决方案,以减少患者的负担.
研究的目的:
- 提出专家建议,以建立AAT的自我管理计划.
- 概述一个框架来实施以患者为中心的AAT自我管理.
主要方法:
- 使用修改名义组技术.
- 两次在线会议与25名多学科专家 (肺病学家,护士,药剂师) 进行.
主要成果:
- 商定的建议涵盖了患者选择标准 (临床和社会).
- 在AAT自我管理中定义了肺病学家,护士和药剂师的角色.
- 制定了护士领导的培训,物流,后续,遵守和患者支持的指导方针.
结论:
- 拟议的建议旨在提高人们的认识,并促进AAT自主管理计划的实施.
- 优化患者在AAT治疗中的体验是关键的预期结果.
- 建议对计划成果进行进一步的研究,特别是从患者的角度来看.
相关概念视频
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


